0001520138-22-000362.txt : 20220816 0001520138-22-000362.hdr.sgml : 20220816 20220816171121 ACCESSION NUMBER: 0001520138-22-000362 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220816 DATE AS OF CHANGE: 20220816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEIZER TERREN S CENTRAL INDEX KEY: 0000904534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39015 FILM NUMBER: 221171034 MAIL ADDRESS: STREET 1: 11111 SANTA MONICABLVD STE.500 CITY: LOS ANGELES STATE: CA ZIP: 90025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVIE INC. CENTRAL INDEX KEY: 0001580149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462510769 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 BUSINESS PHONE: 775-888-3162 MAIL ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 FORMER COMPANY: FORMER CONFORMED NAME: NANOANTIBIOTICS, INC. DATE OF NAME CHANGE: 20130625 4 1 ownership.xml X0306 4 2022-08-15 0 0001580149 BIOVIE INC. BIVI 0000904534 PEIZER TERREN S C/O ACUITAS GROUP HOLDINGS, LLC 120 COLORADO AVENUE, #230 SANTA MONICA CA 90404 1 0 1 0 Common Stock 2022-08-15 4 A 0 3636364 1.65 A 23166210 I By Acuitas Warrants (right to buy) 1.82 2022-08-15 4 A 0 7272728 A 2022-08-15 2027-08-15 Common Stock 7272728 7272728 I By Acuitas On July 15, 2022, BioVie Inc. (the "Issuer") entered into a securities purchase agreement with Acuitas, pursuant to which the Issuer agreed to issue, for an aggregate purchase price of $6,000,000.60, (i) 3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022.3,636,364 shares (the "PIPE Shares") of the Issuer's common stock at a price of $1.65 per share, and (ii) a warrant to purchase 7,272,728 shares of the Issuer's common stock at an exercise price of $1.82, with a term of exercise of five years. The Issuer issued the shares and warrants to Acuitas on August 15, 2022. Acuitas Group Holdings, LLC ("Acuitas"), is an entity beneficially owned and controlled by Terren S. Peizer. /s/ Joanne Wendy Kim, Attorney-in-Fact 2022-08-16